Bruce D Jensen

Title: Innovation and Impact of Inventor Bruce D. Jensen

Introduction

Bruce D. Jensen, an accomplished inventor based in Collegeville, Pennsylvania, holds a remarkable portfolio of six patents. His work focuses primarily on bio-affecting substances and methods for site-selective delivery of therapeutic agents. Through his innovative approach, Jensen has significantly contributed to medical treatments, paving the way for advancements in various therapeutic areas.

Latest Patents

One of Jensen's notable patents is centered on "Compounds, compositions and methods for binding bio-affecting substances." This invention introduces compounds capable of binding therapeutically active substances to lipid-containing biocompatible particles, such as cells or viruses. His invention includes a bio-affecting moiety linked via a linking moiety to a hydrocarbon substituent, designed to retain lipid binding capability. This technology is instrumental for the site-selective delivery of therapeutic agents, specifically noting applications for conditions such as post-angioplasty restenosis, rheumatoid arthritis, tumor cell proliferation (particularly in ovarian cancer), and psoriasis. Another significant patent by Jensen also focuses on "Compounds, compositions and methods for binding bio-affecting substances," which details the preparation and use of compounds to bind bio-affecting substances without adversely affecting the morphology or physiological functionality of bioparticles.

Career Highlights

Throughout his professional journey, Jensen has made impactful contributions while working at several notable companies, including Zynaxis, Inc. and SmithKline Beecham Corporation. These positions have allowed him to collaborate with cutting-edge research and development teams, enhancing his expertise and pushing the boundaries of innovation in healthcare.

Collaborations

Jensen is known for his collaboration with esteemed colleagues, such as Paul K. Horan and Sue Ellen Slezak. These partnerships reflect his commitment to fostering teamwork in research and development, which is essential for advancing innovative solutions within the industry.

Conclusion

Bruce D. Jensen's dedication to innovation in the field of bio-affecting substances marks him as a significant figure in modern medicine. His patents and collaborative efforts continue to inspire advancements in therapeutic delivery methods, showcasing the vital role of inventors in shaping the future of healthcare.